Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-07-02

Clinical Trial Update: Epigenorm Antivir Combined With Acupuncture for the Treatment of Osteoarthritis Patients Who Are Overweight or Obese [NA]

View source ↗

Summary

Clinical trial evaluating Epigenorm Antivir in combination with acupuncture for osteoarthritis in overweight or obese patients. The status of the trial is unkno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Epigenorm Antivir

Snippet

Sponsor: Federal State Budgetary Scientific Institution, Research Institute of Fundamental and Clinical Immunology | Conditions: Osteoarthritis, Overweight and Obesity | NA | Status: UNKNOWN